Colorado BioScience Association Applauds Suspension of the Medical Device Tax and Reauthorization of CHIP

  Congress delays medical device tax for two years Last night, the President signed a continuing resolution (CR) package, which includes a two-year suspension of the device tax retroactive to Dec...

Learn More

Friday Policy Update 1/19/2018

Another week goes by and we continue to strongly advocate for the repeal of the medical device excise tax. This week in DC, the House passed the continuing resolution (CR) to fund the government until...

Learn More

Millennials: Training Talent

State-Funded Program Connects Interns to Bioscience Careers Colorado’s commitment to growing a strong bioscience workforce begins with training up-and-coming talent. A state-funded program focused on...

Learn More

Friday Policy Updates 1/12/2018

UNDER THE GOLD DOME – THE 71ST GENERAL ASSEMBLY The 2018 Colorado Legislative session started this week and kicked off with several industry related health care bills. The CBSA team is already hard at...

Learn More

miRagen: Comprehensive, microRNA Targeted Therapies

Tiny Molecules Modulate Cellular Processes and Can Re-Program Cells Involved in Disease Bill Marshall was in Vienna, Austria, when he got the news. A prominent researcher had, for the first time, foun...

Learn More

Inocucor Raises $9.5 Million in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million

Inocucor Raises $9.5 Million USD ($12.1 Million CAD) in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million USD ($50.9 Million CAD) Ben Belldegr...

Learn More

Friday Policy Updates – 1/5/2018

Under the Gold Dome – The 71st General Assembly The 2018 Colorado Legislative session begins next Wednesday, January 10th! The CBSA team will be busy advocating on behalf of the Colorado Bioscience in...

Learn More

Millennials in Colorado

Expanding our Workforce, Inspiring Our Companies Colorado boasts the fastest-growing Millennial population in the United States. This large demographic group is generally recognized as Americans born...

Learn More

At the Center of Everything

Our Location Gives BioScience Companies an Advantage Many factors contribute to Colorado’s reputation as an exceptional place to start, grow, commercialize or relocate a life science business. Our col...

Learn More

2017 Breaks Bioscience Records

$1.2 Billion Year Doubles Amount Raised in 2016 Colorado’s life science companies raised a record $1.2 billion in 2017, doubling the funds raised in the previous year. The funding came through venture...

Learn More